أعرض في EDS

Supplementary Figure from First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy

التفاصيل البيبلوغرافية
العنوان: Supplementary Figure from First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy
المؤلفون: Victor Moreno, Harvey Wong, Raquel Izumi, Xin Huang, Ahmed M. Hamdy, Joy M. Greer, Melanie M. Frigault, Oliver Boix, Claudia Merz, Isabelle Genvresse, Ray Valencia, Daniel Morillo, Raul Cordoba, Grzegorz Nowakowski, Emerson Lim, Valentina Boni, Jennifer R. Diamond
بيانات النشر: American Association for Cancer Research (AACR), 2023.
سنة النشر: 2023
الوصف: Supplementary Figure from First-in-Human Dose-Escalation Study of Cyclin-Dependent Kinase 9 Inhibitor VIP152 in Patients with Advanced Malignancies Shows Early Signs of Clinical Efficacy
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f2a6700edabfc66a9670dca8c598725
https://doi.org/10.1158/1078-0432.22488164.v1
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....4f2a6700edabfc66a9670dca8c598725
قاعدة البيانات: OpenAIRE
الوصف
الوصف غير متاح.